您当前的位置:
首页 >
文章列表页 >
JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
Full-length article | 更新时间:2023-08-29
    • JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1

    • Genes & Diseases   Vol. 10, Issue 5, (2023)
    • 作者机构:

      Key Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University,Chongqing,China,400016

    • DOI:10.1016/j.gendis.2022.07.006    

      CLC:
    • Published:2023,

      Published Online:1 September 2023,

    扫 描 看 全 文

  • Junping Liu, Yutong Shi, Minmin Wu, et al. JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1. [J]. Genes & Diseases 10(5).(2023) DOI: 10.1016/j.gendis.2022.07.006.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

The journey towards physiology and pathology: Tracing the path of neuregulin 4
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis
LncRNA H19 mediates BMP9-induced angiogenesis in mesenchymal stem cells by promoting the p53-Notch1 angiogenic signaling axis
Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy

Related Author

Liang Guo
Wangjing Mu
Hongyang Luo
Jieying Zhu
Min Chen
Yan Zhao
Cheng Xing
Yating Deng

Related Institution

School of Exercise and Health and Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport
Hunan Engineering Research Center of Cell Immunotherapy for Hematopoietic Malignancies, The Second Xiangya Hospital, Central South University
Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University
Department of Hematology, The Second Xiangya Hospital, Central South University
Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education
0